Leaps by Bayer

General contacts
Investor type

CVC

Founded

2015

AUM

-

Location

Leverkusen, North Rhine-Westphalia, Germany

Investment Ticket

$0-1 m

Investment Stage

Series A Seed Series B

Region of investment

North America Europe
Investor profile last updated: 27 May, 2026

Profile

Leaps by Bayer is a corporate venture capital arm of Bayer, based in Leverkusen, Germany, and founded in 2015. The firm is focused on investing in life sciences, particularly in biotechnology and agriculture, aiming to address ten significant global challenges. The team consists of around 11 professionals who collaborate with leading experts to drive transformative therapies and technologies.

Leaps by Bayer invests in sectors such as biotechnology, agriculture, and scientific breakthroughs, with a focus on Series A rounds. The firm typically invests in the United States, Canada, and Germany. They do not specify a typical check size, but their investments are aimed at early revenue stages. The firm has a diverse portfolio, including companies like Recursion Pharmaceuticals and Senti Biosciences.

Notable investments by Leaps by Bayer include Ukko - drug discovery, Indapta Therapeutics - drug discovery, Sound Agriculture - cultivation, and EarthOptics - business/productivity software. These investments reflect their commitment to addressing global challenges through innovative solutions in health and agriculture.

Industry

Agriculture Financial Services Fintech Food and Beverage Foodtech Healthcare Services Robotics Software Life Sciences HealthTech

Contacts

Name
Title
Email
Social Networks
avatar
Susanne Machacz Director, New Product Commercialization
Director, New Product Commercialization
s•••@•••
LinkedIn
avatar
Omar Reyes Director, New Product Commercialization
Director, New Product Commercialization
o•••@•••
LinkedIn
Upgrade to see contacts
avatar
y1rZzsqaLoMTxXCP y1rZzsqaLoMTxXCP
y1rZzsqaLoMTxXCP
[email protected]
linkedin twitter
avatar
y1rZzsqaLoMTxXCP y1rZzsqaLoMTxXCP
y1rZzsqaLoMTxXCP
[email protected]
linkedin twitter
avatar
y1rZzsqaLoMTxXCP y1rZzsqaLoMTxXCP
y1rZzsqaLoMTxXCP
[email protected]
linkedin twitter
Investment-team contacts for Leaps by Bayer — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Leaps by Bayer

Leaps by Bayer operates as a corporate VC (CVC). It backs companies at Series A, Seed and Series B, writing tickets of $0-1 m.
Leaps by Bayer is located in Leverkusen, North Rhine-Westphalia, Germany.
Leaps by Bayer was founded in 2015.
Leaps by Bayer invests in companies and startups in Agriculture, Financial Services, Fintech, Food and Beverage, Foodtech, Healthcare Services, Robotics, Software, Life Sciences, HealthTech.
Leaps by Bayer invests in companies and startups in North America, Europe.
Leaps by Bayer invests in companies and startups at Series A, Seed, Series B.
Leaps by Bayer usually invests $0-1 m on average.
Leaps by Bayer can be reached through its website leaps.bayer.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Leaps by Bayer — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Leaps by Bayer directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 27 May, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.